0

Lupus Erythematosus Collection
 1-20 of 249 Articles
Original Research |  11 November 2014 ONLINE FIRST
Multitarget Therapy for Induction Treatment of Lupus Nephritis: A Randomized, Controlled TrialMultitarget Therapy for Induction Treatment of Lupus Nephritis
Zhihong Liu, MD; Haitao Zhang, MD; Zhangsuo Liu, MD; et al.
Ann Intern Med. Published online 11 November 2014 doi:10.7326/M14-1030
Updates |  17 July 2012
Update in Rheumatology: Evidence Published in 2011
Lindsy J. Forbess, MD; Anne R. Bass, MD
Ann Intern Med. 2012;157(2):114-119. doi:10.7326/0003-4819-157-2-201204030-00408
Editorials |  21 June 2005
Help for Menopausal Patients with Lupus?
Evelyn V. Hess, MD
Ann Intern Med. 2005;142(12_Part_1):1014-1015. doi:10.7326/0003-4819-142-12_Part_1-200506210-00011
Articles |  21 June 2005
The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial
Jill P. Buyon, MD; Michelle A. Petri, MD, MPH; Mimi Y. Kim, ScD; et al.
Ann Intern Med. 2005;142(12_Part_1):953-962. doi:10.7326/0003-4819-142-12_Part_1-200506210-00004
Editorials |  21 August 2001
The Treatment of Lupus Nephritis: Revisiting Galen
Edmund J. Lewis, MD
Ann Intern Med. 2001;135(4):296-298. doi:10.7326/0003-4819-135-4-200108210-00014
Articles |  21 August 2001
Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis
Gabor G. Illei, MD; Howard A. Austin, MD; Marianna Crane, NP; et al.
Ann Intern Med. 2001;135(4):248-257. doi:10.7326/0003-4819-135-4-200108210-00009
Brief Communications |  18 April 2000
Potentiation of Vitamin K Antagonists by High-Dose Intravenous Methylprednisolone
Nathalie Costedoat-Chalumeau, MD; Zahir Amoura, MD; Guy Aymard, PhD; et al.
Ann Intern Med. 2000;132(8):631-635. doi:10.7326/0003-4819-132-8-200004180-00005
Currents |  15 December 1998
New Approaches for Treatment of Systemic Lupus Erythematosus
Philip M. Bulman; Gene Hunder, MD, MS
Ann Intern Med. 1998;129(12):1095-1096. doi:10.7326/0003-4819-129-12-199812150-00051
Articles |  15 January 1998
The Pathophysiologic Roles of Interleukin-6 in Human Disease
Dimitris A. Papanicolaou, MD; Ronald L. Wilder, MD, PhD; Stavros C. Manolagas, MD, PhD; et al.
Ann Intern Med. 1998;128(2):127-137. doi:10.7326/0003-4819-128-2-199801150-00009
Articles |  1 August 1997
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Stephan Moll, MD; Thomas L. Ortel, MD, PhD
Ann Intern Med. 1997;127(3):177-185. doi:10.7326/0003-4819-127-3-199708010-00001
Editorials |  15 January 1997
DNA and the Immune System
David S. Pisetsky, MD, PhD
Ann Intern Med. 1997;126(2):169-171. doi:10.7326/0003-4819-126-2-199701150-00015
Articles |  1 October 1996
Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus Nephritis: A Randomized, Controlled Trial
Mark F. Gourley, MD; Howard A. Austin III, MD; Dorothy Scott, MD; et al.
Ann Intern Med. 1996;125(7):549-557. doi:10.7326/0003-4819-125-7-199610010-00003
Reviews |  1 July 1995
Systemic Lupus Erythematosus: Emerging Concepts: Part 2: Dermatologic and Joint Disease, the Antiphospholipid Antibody Syndrome, Pregnancy and Hormonal Therapy, Morbidity and Mortality, and Pathogenesis
Dimitrios T. Boumpas, MD; Barri J. Fessler, MD; Howard A. Austin III, MD; et al.
Ann Intern Med. 1995;123(1):42-53. doi:10.7326/0003-4819-123-1-199507010-00007
Reviews |  15 June 1995
Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease
Dimitrios T. Boumpas, MD; Howard A. Austin, MD; Barri J. Fessler, MD; et al.
Ann Intern Med. 1995;122(12):940-950. doi:10.7326/0003-4819-122-12-199506150-00009
Brief Communications |  15 March 1995
Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus
Jorge Sanchez-Guerrero, MD, MSc; Matthew H. Liang, MD, MPH; Elizabeth W. Karlson, MD; et al.
Ann Intern Med. 1995;122(6):430-433. doi:10.7326/0003-4819-122-6-199503150-00005
Articles |  15 March 1994
Antiphospholipid Antibodies in Predicting Adverse Pregnancy Outcome: A Prospective Study
Anne Lynch, MB; Richard Marlar, PhD; James Murphy, PhD; et al.
Ann Intern Med. 1994;120(6):470-475. doi:10.7326/0003-4819-120-6-199403150-00004
Articles |  15 October 1993
Reliability of Histologic Scoring for Lupus Nephritis: A Community-based Evaluation
Richard M. Wernick, MD; David L. Smith, MD; Donald C. Houghton, MD; et al.
Ann Intern Med. 1993;119(8):805-811. doi:10.7326/0003-4819-119-8-199310150-00006
Articles |  1 September 1993
Risk for Sustained Amenorrhea in Patients with Systemic Lupus Erythematosus Receiving Intermittent Pulse Cyclophosphamide Therapy
Dimitrios T. Boumpas, MD; Howard A. Austin, MD; Ellen M. Vaughan, RN; et al.
Ann Intern Med. 1993;119(5):366-369. doi:10.7326/0003-4819-119-5-199309010-00003
Editorials |  1 July 1993
Superantigens and Microbial Pathogenesis
Dennis D. Taub, PhD; Kenneth J. Blank, PhD
Ann Intern Med. 1993;119(1):89-90. doi:10.7326/0003-4819-119-1-199307010-00016
Articles |  15 August 1992
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
Michael H. Rosove, MD; Petronella M. C. Brewer, RN
Ann Intern Med. 1992;117(4):303-308. doi:10.7326/0003-4819-117-4-303
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)